TrialAnnals of transplantation2019

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report.

Claudia Bösmüller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.